Subscribe to RSS
DOI: 10.1055/s-0030-1255747
© Georg Thieme Verlag KG Stuttgart · New York
Höhere Feldstärken in der kardiovaskulären MRT
Publication History
Publication Date:
21 September 2010 (online)
![](https://www.thieme-connect.de/media/kardiologie-u2d/201003/lookinside/thumbnails/10.1055-s-0030-1255747-1.jpg)
Abstract
Today Cardiovascular Magnetic Resonance at 1,5 Tesla has a defined place in clinical cardiology routine assessment. That depends on availability and investigator experience. The role of higher field strengths in clinical routine is under investigation. One can expect, that a selected, focused application will provide an added value. That will depend on the provided diagnostic accuracy and an improvement of scan comfort itself (e. g. scan-time and patient comfort)
In summary, higher field strengths itself cannot guarantee an improved diagnostic accuracy in cardiology. Already today, CMR itself can provide a reliable and unique diagnosis in clinical routine.
Literatur
- 1 Deutsche Kardiologische Gesellschaft . Klinische Indikationen für die kardiovaskuläre Magnetresonanztomographie(CMR). Clin Res Cardiol Suppl. 2007; 2 77-96
- 2 Pettigrew R I. Dynamic cardiac MR imaging. Techniques and applications. Radiol Clin North Am. 1989; 27 1183-1203
- 3 Kollia K, Maderwald S, Putzki N. et al . First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5 T and 7 T. AJNR Am J Neuroradiol. 2009; 30 699-702
- 4 Friedrich M G, Abdel-Aty H, Taylor A. et al . The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. JACC. 2008; 51 1581-1587
- 5 Aletras A, Tilak G S, Natanzon A. et al . Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006; 113 1865-1870
- 6 Bruder O, Schneider S, Nothnagel D. et al . EuroCMR (European Cardiovascular Magnetic Resonance) Registry Results of the German Pilot Phase. J Am Coll Cardiol. 2009; 15 1452-1466
- 7 Schulz-Menger J, Wassmuth R, Abdel-Aty H. et al . Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart. 2006; 92 399-400
- 8 Maceira A M, Joshi J, Prasad S K. et al . Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005; 111 186-183
- 9 Becker M, Frauenrath T, Hezel F. et al . Comparison of left ventricular function assessment using phonocardiogram- and electrocardiogram-triggered 2D SSFP CINE MR imaging at 1.5 T and 3.0 T. Eur Radiol. 2009; 5 344-355
- 10 Anderson L J, Wonke B, Prescott E. et al . Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet. 2002; 360 516-520
- 11 Gutberlet M, Noeske R, Schwinge K. et al . Comprehensive cardiac magnetic resonance imaging at 3.0 Tesla: feasibility and implications for clinical applications. Invest Radiol. 2006; 41 154-167
- 12 Snyder C J, DelaBarre L, Metzger G J. et al . Initial results of cardiac imaging at 7 Tesla. Magn Reson Med. 2009; 61 517-524
- 13 von Knobelsdorff-Brenkenhoff F, Frauenrath T, Prothmann M. et al . Cardiac chamber quantification using magnetic resonance imaging at 7 Tesla – a pilot study. Eur Radiol. 2010; 17 (epub ahead of print)
Prof. Dr. Jeanette Schulz-Menger
Arbeitsgruppe Kardiale MRT
Charité Campus Buch, Humboldt-Universität Berlin, ECRC
HELIOS Klinikum Berlin Buch, Klinik für Kardiologie und Nephrologie
Schwanebecker Chaussee 50
13125 Berlin, Germany
Email: jeanette.schulz-menger@charite.de